65 I B, drugs, pharmaceuticals, & hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79721D0261
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • 65IB Solicitation number
Last date to order 93% complete
IDV ceiling
$48,653,265.00
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

GSA issued a Federal Supply Schedule contract to Aveo Pharmaceuticals, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) schedule on October 15, 2021, with a ceiling value of $48,653,265.

The contract covers Special Item Number 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products. This is a multiple-award schedule vehicle, enabling ordering federal agencies to place orders directly against Aveo's GSA price list without conducting separate competitions. The contract is registered to Veterans Integrated Service Network 12 and carries no socioeconomic set-aside. Performance extends through March 31, 2027. The source indicates this award involved a contract extension, reflecting renewal or modification under GSA's schedule administration rules.

Aveo operates under the brand Aveo Oncology and maintains GSA pricing for pharmaceutical and hematology products available to any federal agency with schedule access.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00020 · Contract extension $0
Supplemental Agreement for work within scope P00019 · Massmod. $0
Add Subcontract Plan P00018 · 2026 subplan. $0
Supplemental Agreement for work within scope P00017 · 2026 PL. $0
Supplemental Agreement for work within scope P00016 · NDC change. $0
Rerepresentation of Non-Novated Merger/Acquisition P00015 · Business size update. $0
Vendor DUNS or Name Change - Non-Novation P00014 · DBA removal. $0
Supplemental Agreement for work within scope P00013 · 2025 PL. $0
Supplemental Agreement for work within scope P00012 · Increase $0
Supplemental Agreement for work within scope P00011 · Address change $0
Supplemental Agreement for work within scope P00010 · Admin correction to MODP00009 (OGA prices) $0
Supplemental Agreement for work within scope P00009 · 2024 PL updates. $0
Supplemental Agreement for work within scope P00008 $0
Supplemental Agreement for work within scope P00007 · OGA EPA $0
Supplemental Agreement for work within scope P00006 · Price correction. $0
Supplemental Agreement for work within scope P00005 · 2023 PL update. $0
Supplemental Agreement for work within scope P00004 · 42-2A EPA. $0
Supplemental Agreement for work within scope P00003 · 42-2A PPR for OGA. $0
Supplemental Agreement for work within scope P00002 · 2022 public law pricing updates $0
Supplemental Agreement for work within scope P00001 · 65IB drugs, pharmaceuticals and hematology related products $0
Original award $0
Show all 21

Quick answers

Who was awarded contract 36F79721D0261?

36F79721D0261 was awarded to Aveo Pharmaceuticals, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on October 15, 2021.

How much is contract 36F79721D0261 worth?

36F79721D0261's own ceiling is $48,653,265.

Who can order from contract 36F79721D0261?

36F79721D0261 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79721D0261 part of a contract vehicle?

Yes. 36F79721D0261 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79721D0261 competed?

The extent of competition for 36F79721D0261 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV